|
female |
15 |
|
adult |
14 |
|
humans |
14 |
|
hong kong |
9 |
|
chinese |
8 |
|
osteoporosis |
7 |
|
asian continental ancestry group |
6 |
|
body weight |
6 |
|
menopause |
6 |
|
pregnancy |
6 |
|
risk factors |
6 |
|
time factors |
6 |
|
actinomyces - classification - cytology - isolation & purification - physiology |
5 |
|
actinomyces hongkongensis |
5 |
|
actinomycosis - microbiology |
5 |
|
age factors |
5 |
|
anaerobiosis |
5 |
|
bacterial typing techniques |
5 |
|
bone loss |
5 |
|
chinese herbal medicine |
5 |
|
dna, bacterial - chemistry - isolation & purification |
5 |
|
dna, ribosomal - chemistry - isolation & purification |
5 |
|
er-xian decoction |
5 |
|
estradiol - blood |
5 |
|
estrogens - deficiency |
5 |
|
follicle stimulating hormone - blood |
5 |
|
genes, rrna |
5 |
|
hot flushes |
5 |
|
male |
5 |
|
menotropins - therapeutic use |
5 |
|
middle aged |
5 |
|
molecular sequence data |
5 |
|
ovulation induction |
5 |
|
patient |
5 |
|
pelvic actinomycosis |
5 |
|
pelvic inflammatory disease - microbiology |
5 |
|
phylogeny |
5 |
|
quality of life |
5 |
|
rna, ribosomal, 16s - genetics |
5 |
|
sequence analysis, dna |
5 |
|
adolescent |
4 |
|
bone density - physiology |
4 |
|
bone mineral density |
4 |
|
china |
4 |
|
chinese women |
4 |
|
demography |
4 |
|
estrogens - urine |
4 |
|
growth curve |
4 |
|
infant, newborn |
4 |
|
karyotype |
4 |
|
ovulation |
4 |
|
practice guidelines |
4 |
|
turner's syndrome |
4 |
|
ultrasound |
4 |
|
women |
4 |
|
absorptiometry, photon |
3 |
|
aged |
3 |
|
aged, 80 and over |
3 |
|
amenorrhea - drug therapy |
3 |
|
analysis of variance |
3 |
|
antibodies - analysis |
3 |
|
area under curve |
3 |
|
body height |
3 |
|
body mass index |
3 |
|
bone and bones - pathology |
3 |
|
bone density |
3 |
|
calcaneus |
3 |
|
calcaneus - ultrasonography |
3 |
|
cervix mucus - cytology |
3 |
|
china - epidemiology |
3 |
|
cross-sectional studies |
3 |
|
depot-medroxyprogesterone acetate |
3 |
|
estrogen replacement therapy |
3 |
|
fracture risk |
3 |
|
fractures, bone - epidemiology - etiology - pathology |
3 |
|
gynecologic cancer |
3 |
|
infertility |
3 |
|
linear models |
3 |
|
longitudinal |
3 |
|
menopausal transition |
3 |
|
menopause - physiology |
3 |
|
menstrual cycle |
3 |
|
menstruation disturbances - drug therapy |
3 |
|
normal |
3 |
|
oligomenorrhea - drug therapy |
3 |
|
osteoporosis, postmenopausal - epidemiology - etiology - pathology |
3 |
|
osteoporosis, postmenopausal - physiopathology - ultrasonography |
3 |
|
predictive value of tests |
3 |
|
premenopause - physiology |
3 |
|
prolactin - blood |
3 |
|
prospective studies |
3 |
|
psychosocial adjustment |
3 |
|
reference values |
3 |
|
retrospective studies |
3 |
|
risk assessment |
3 |
|
sperm agglutination |
3 |
|
sperm motility |
3 |
|
spermatozoa - immunology |
3 |
|
spinal fractures - physiopathology - ultrasonography |
3 |
|
ultrasonography |
3 |
|
vagina - cytology |
3 |
|
abortifacient agents - pharmacology |
2 |
|
abortifacient agents, nonsteroidal |
2 |
|
abortifacient agents, nonsteroidal - pharmacology |
2 |
|
abortion, induced |
2 |
|
abortion, spontaneous - blood |
2 |
|
abortion, spontaneous - blood - chemically induced - diagnosis |
2 |
|
alprostadil - administration & dosage - analogs & derivatives |
2 |
|
alprostadil - analogs & derivatives |
2 |
|
analgesia: patient-controlled, morphine |
2 |
|
animals |
2 |
|
antiemetic: tropisetron, ondansetron |
2 |
|
antiemetics - therapeutic use |
2 |
|
antigens, cd - analysis |
2 |
|
antigens, cd4 - analysis |
2 |
|
apgar score |
2 |
|
asia |
2 |
|
asphyxia neonatorum - etiology |
2 |
|
autoantibodies - analysis |
2 |
|
autoimmune diseases - etiology |
2 |
|
b-lymphocyte subsets - immunology |
2 |
|
b-lymphocytes - pathology |
2 |
|
beta-endorphin |
2 |
|
biological assay |
2 |
|
birth injuries - etiology |
2 |
|
birth weight |
2 |
|
cancer |
2 |
|
cd4-cd8 ratio |
2 |
|
cell count |
2 |
|
cervical cancer |
2 |
|
cervix mucus - analysis |
2 |
|
cervix uteri - drug effects |
2 |
|
cesarean section |
2 |
|
chorionic gonadotropin - administration & dosage - blood - pharmacology |
2 |
|
chorionic gonadotropin - blood |
2 |
|
chorionic gonadotropin, beta subunit, human |
2 |
|
clomiphene - adverse effects - analogs & derivatives - therapeutic use |
2 |
|
cricetinae |
2 |
|
culture |
2 |
|
developing countries |
2 |
|
diagnosis, differential |
2 |
|
dihydrotestosterone - pharmacology |
2 |
|
dilatation - methods |
2 |
|
endorphins - blood |
2 |
|
ethnic groups |
2 |
|
extraction, obstetrical - instrumentation |
2 |
|
fallopian tubes |
2 |
|
far east |
2 |
|
fear |
2 |
|
fertilization |
2 |
|
fertilization in vitro - drug effects |
2 |
|
genital diseases, female - diagnosis |
2 |
|
gonadal dysgenesis - immunology |
2 |
|
gonadal steroid hormones - blood |
2 |
|
gonadotropins, pituitary - blood |
2 |
|
guinea pigs |
2 |
|
gynecologic surgical procedures |
2 |
|
hemorrhage - etiology |
2 |
|
hong kong chinese |
2 |
|
hysterectomy - psychology |
2 |
|
immunoenzyme techniques |
2 |
|
immunoglobulin g - blood |
2 |
|
immunoglobulins - blood |
2 |
|
indoles - therapeutic use |
2 |
|
infertility, female - etiology |
2 |
|
infertility, male - etiology |
2 |
|
infertility, male - physiopathology |
2 |
|
injections, intramuscular |
2 |
|
jaundice, neonatal - etiology |
2 |
|
laparotomy |
2 |
|
long-term |
2 |
|
longitudinal study |
2 |
|
luteinizing hormone - blood |
2 |
|
lymphocyte subsets |
2 |
|
lymphocytes - classification |
2 |
|
menopause - immunology |
2 |
|
menopause, premature - blood - immunology |
2 |
|
menotropins - adverse effects |
2 |
|
mifepristone - administration & dosage - adverse effects |
2 |
|
monitoring, physiologic |
2 |
|
ondansetron - therapeutic use |
2 |
|
osteochondrodysplasias - diagnosis |
2 |
|
ovarian diseases - immunology |
2 |
|
ovarian diseases - immunology - metabolism |
2 |
|
ovarian hyperstimulation syndrome - chemically induced - ultrasonography |
2 |
|
ovary - ultrasonography |
2 |
|
ovulation induction - methods |
2 |
|
papillomavirus vaccines |
2 |
|
patient education as topic |
2 |
|
peptide fragments - administration & dosage - blood - pharmacology |
2 |
|
peptide fragments - blood |
2 |
|
population |
2 |
|
population characteristics |
2 |
|
pregnancy - blood |
2 |
|
pregnancy proteins - analysis |
2 |
|
pregnancy trimester, first |
2 |
|
pregnancy, multiple |
2 |
|
pregnancy-specific beta 1-glycoproteins - analysis |
2 |
|
prenatal diagnosis |
2 |
|
primary ovarian insufficiency - drug therapy - immunology |
2 |
|
progesterone - blood |
2 |
|
prolactin - analysis - blood |
2 |
|
prostaglandins e, synthetic - adverse effects - pharmacology |
2 |
|
psychosocial study |
2 |
|
radioimmunoassay |
2 |
|
reproduction |
2 |
|
self concept |
2 |
|
sexual behavior |
2 |
|
sperm count |
2 |
|
sperm motility - drug effects |
2 |
|
spermatozoa - drug effects |
2 |
|
suppositories |
2 |
|
surgery: gynaecological, laparotomy |
2 |
|
t-lymphocyte subsets - immunology |
2 |
|
t-score |
2 |
|
testosterone - pharmacology |
2 |
|
thanatophoric dysplasia - diagnosis |
2 |
|
therapeutics |
2 |
|
trophoblastic neoplasms - psychology |
2 |
|
uterine neoplasms - psychology |
2 |
|
vacuum extraction, obstetrical - adverse effects - instrumentation |
2 |
|
vagina |
2 |
|
vagina - injuries |
2 |
|
abortifacient agents, nonsteroidal - adverse effects - therapeutic use |
1 |
|
abortion applicants - psychology |
1 |
|
abortion, induced - methods - psychology |
1 |
|
acceptability |
1 |
|
adenocarcinoma - pathology - prevention and control - virology |
1 |
|
adenocarcinoma in situ (ais) |
1 |
|
adhesives |
1 |
|
alprostadil - adverse effects - analogs & derivatives - therapeutic use |
1 |
|
anger |
1 |
|
antibodies, viral - analysis - biosynthesis - immunology |
1 |
|
biochemical markers |
1 |
|
blood vessel |
1 |
|
bone turnover |
1 |
|
calcium |
1 |
|
cancer vaccines |
1 |
|
cancer vaccines - therapeutic use |
1 |
|
carcinoma in situ - prevention and control |
1 |
|
catheterization - methods |
1 |
|
certification |
1 |
|
cervical intraepithelial neoplasia |
1 |
|
cervical intraepithelial neoplasia - pathology - prevention and control - virology |
1 |
|
cervical intraepithelial neoplasia - prevention & control |
1 |
|
cervical intraepithelial neoplasia - prevention and control |
1 |
|
cervical intraepithelial neoplasia - prevention and control - virology |
1 |
|
china - ethnology |
1 |
|
chinese medicine |
1 |
|
chorionic gonadotropin - administration & dosage |
1 |
|
cicatrix - physiopathology - ultrasonography |
1 |
|
climacteric symptoms |
1 |
|
clinical trial |
1 |
|
compliance |
1 |
|
complications |
1 |
|
condylomata acuminata - epidemiology - immunology - prevention & control |
1 |
|
counseling |
1 |
|
creatinine - urine |
1 |
|
depression |
1 |
|
diet |
1 |
|
diethylstilbestrol - therapeutic use |
1 |
|
dilatation |
1 |
|
education, medical, continuing |
1 |
|
educational status |
1 |
|
emergencies |
1 |
|
estrogens - blood - urine |
1 |
|
estrogens - therapeutic use |
1 |
|
estrogens, conjugated (usp) - therapeutic use |
1 |
|
estrone - analogs & derivatives - urine |
1 |
|
exercise |
1 |
|
fallopian tubes - drug effects - pathology |
1 |
|
family |
1 |
|
fetal blood - analysis |
1 |
|
follicle-stimulating hormone |
1 |
|
follow-up studies |
1 |
|
foreign bodies - diagnosis |
1 |
|
foreign-body migration - diagnosis |
1 |
|
genital diseases, female - prevention and control - virology |
1 |
|
genital warts |
1 |
|
gonadal dysgenesis - drug therapy |
1 |
|
gonadotropin |
1 |
|
haematoma |
1 |
|
health knowledge, attitudes, practice |
1 |
|
hormonal therapy |
1 |
|
hormone |
1 |
|
hormone replacement therapy |
1 |
|
hormones - blood |
1 |
|
hpv |
1 |
|
human papillomavirus |
1 |
|
human papillomavirus (hpv) |
1 |
|
human papillomavirus 11 - immunology |
1 |
|
human papillomavirus 16 - immunology |
1 |
|
human papillomavirus 18 - immunology |
1 |
|
human papillomavirus 6 - immunology |
1 |
|
hypoestrogenism |
1 |
|
immunization schedule |
1 |
|
infertility, female - drug therapy |
1 |
|
laminaria |
1 |
|
laparoscopy |
1 |
|
leiomyoma - surgery |
1 |
|
levonorgestrel device |
1 |
|
medical curriculum |
1 |
|
medical education |
1 |
|
medroxyprogesterone - analogs & derivatives - therapeutic use |
1 |
|
medroxyprogesterone acetate |
1 |
|
melatonin |
1 |
|
melatonin - blood |
1 |
|
menopausal symptoms |
1 |
|
menopausal symptoms score |
1 |
|
menorrhagia |
1 |
|
menotropins - administration & dosage |
1 |
|
mesentery |
1 |
|
mifepristone - adverse effects - therapeutic use |
1 |
|
monitoring and evaluation |
1 |
|
monitoring, physiologic - methods |
1 |
|
multicenter studies as topic |
1 |
|
myometrium |
1 |
|
natural history |
1 |
|
observational study |
1 |
|
papillomaviridae - immunology |
1 |
|
papillomaviridae - isolation and purification |
1 |
|
papillomavirus infections - immunology - pathology - prevention & control |
1 |
|
papillomavirus infections - pathology - prevention and control - virology |
1 |
|
papillomavirus infections - prevention & control |
1 |
|
papillomavirus infections - prevention and control |
1 |
|
papillomavirus vaccines - immunology |
1 |
|
papillomavirus vaccines - therapeutic use |
1 |
|
patient acceptance of health care |
1 |
|
phenol |
1 |
|
phenols |
1 |
|
pilot projects |
1 |
|
postpartum period - blood |
1 |
|
prophylactic vaccine |
1 |
|
randomized controlled trials as topic |
1 |
|
reverse transcriptase polymerase chain reaction |
1 |
|
seaweed |
1 |
|
sex factors |
1 |
|
single person - psychology |
1 |
|
sterilization, reproductive - methods |
1 |
|
steroid |
1 |
|
trauma |
1 |
|
uterine cervical neoplasms - pathology - prevention and control - virology |
1 |
|
uterine cervical neoplasms - prevention & control |
1 |
|
uterine cervical neoplasms - prevention and control - virology |
1 |
|
uterine neoplasms - surgery |
1 |
|
uterus - physiopathology - surgery - ultrasonography |
1 |
|
vaccine |
1 |
|
vacuum curettage - psychology |
1 |
|
vagina - pathology |
1 |
|
vaginal smears |
1 |
|
vulva - pathology |
1 |
|
wound healing |
1 |
|
young adult |
1 |
|
young women |
1 |
